Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ROPINIROLE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for ROPINIROLE EXTENDED-RELEASE TABLETS. ROPINIROLE extended-release tablets, for oral use Initial U.S. Approval: 1997
Medication labelWhy this: Advisory · dailymed-prescription
Ropinirole extended-release tablets are indicated for the treatment of Parkinson’s disease.
- generic_name
- ropinirole
- product_names
- Ropinirole
- ndc
- 46708-262, 46708-263, 46708-264, 46708-265, 46708-266, 46708-262-30, 46708-262-90, 46708-262-31, 46708-262-91, 46708-262-10, 46708-262-71, 46708-263-30, 46708-263-90, 46708-263-31, 46708-263-91, 46708-263-10, 46708-263-71, 46708-264-30, 46708-264-90, 46708-264-31, 46708-264-91, 46708-264-10, 46708-264-71, 46708-265-30, 46708-265-90, 46708-265-31, 46708-265-91, 46708-265-10, 46708-265-71, 46708-266-30, 46708-266-90, 46708-266-31, 46708-266-91, 46708-266-10, 46708-266-71
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en